Literature DB >> 27756735

Optimal dosing of rivaroxaban is undefined.

Thomas J Moore1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27756735     DOI: 10.1136/bmj.i5549

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  2 in total

1.  Incomplete Resolution of Deep Vein Thromboses during Rivaroxaban Therapy.

Authors:  Jonathan M Yaghoubian; Jacob Adashek; Bahareh Yaghoubian-Yazi; Menachem Nagar; Nojan Toomari; Richard J Pietras; Uri M Ben-Zur
Journal:  Case Rep Cardiol       Date:  2017-07-30

2.  Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study.

Authors:  Gilda Denise Zielinski; Nienke van Rein; Martina Teichert; Frederikus A Klok; Frits R Rosendaal; Felix J M van der Meer; Menno V Huisman; Suzanne C Cannegieter; Willem M Lijfering
Journal:  Res Pract Thromb Haemost       Date:  2019-10-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.